Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-009172

Options or other derivatives

  • Director acquired 11,066 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RECTOR DAVID · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-05-20 Grant or award : show line 1 in the form Common Stock Option +11,066 $0.61 2020-05-20 11,066 452,646 D
Loading xslF345X03/edgar.xml…